Foldable Capsular Vitreous Body implant for post-traumatic Phthisical Eye: A Case Report

Year 2019, Volume: 1 Issue: 3, 126 - 130, 31.12.2019

Hussain Ahmed Khaqan , Hasnain Muhammad Buksh , Usman Imtiaz Ateeq-ur Rehman Raheela Naz Usman Shabbir

https://izlik.org/JA83BF99JA

Abstract

Abstract

Purpose:
To analyze the outcomes of foldable capsular vitreous body injected in a
post-traumatic phthysical eye.

Case
presentation: A 19 year old male patient presented to ophthalmology department
with left post-traumatic phthisical eye , who had previously undergone
corneoscleral tear repair due to a penetrating trauma to his left eye one year
back. On ocular examination , there is a corneo scleral scar mark, aniridia ,
aphakia and retina incarcerated in the scar. He was injected with a foldable
capuslar vitreous body.

Conclusion:
Our case report of foldable capsular vitreous body gives an excellent cosmesis
for the physical eye.

Keywords

foldable capsular vitreous body

References

• 1) Gao QY, Fu Y, Hui YN. Vitreous substitutes: challenges and directions. International journal of ophthalmology. 2015;8(3):437.
• 2) Lin X, Wang Z, Jiang Z, Long C, Liu Y, Wang P, Jin C, Yi C, Gao Q. Preliminary Efficacy And Safety Of A Silicone Oil–filled Foldable Capsular Vitreous Body In The Treatment Of Severe Retinal Detachment. Retina. 2012 Apr 1;32(4):729-41.
• 3) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
• 4) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011).
• 5) Swindle-Reilly, K. E. et al. Rabbit study of an in situ forming hydrogel vitreous substitute. Invest Ophthalmol Vis Sci. 50, 4840–4846 (2009).
• 6) Federman, J. L. & Schubert, H. D. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 95, 870–876 (1988).
• 7) Valone Jr, J. & McCarthy, M. Emulsified anterior chamber silicone oil and glaucoma. Ophthalmology. 101, 1908–1912 (1994).
• 8) Ichhpujani, P., Jindal, A. & Jay Katz, L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 247, 1585–1593 (2009).
• 9) Foster, W. J. Vitreous Substitutes. Expert Rev Ophthalmol 3, 211–218 (2008).
• 10) Li, W. et al. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment. Eye (Lond). 24, 21–28 (2010).
• 11) Stefansson, E., Anderson, M. M., Jr, Landers, M. B., III, Tiedeman, J. S. & McCuen, B. W., II Refractive changes from use of silicone oil in vitreous surgery. Retina. 8, 20–23 (1988).
• 12) Kleinberg, T. T., Tzekov, R. T., Stein, L., Ravi, N. & Kaushal, S.Vitreous substitutes: a comprehensive review. Surv Ophthalmol.56, 300–323 (2011).
• 13) Baino, F. Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends. Acta Biomater. 7, 921–935 (2011).
• 14) Pastor, J. C. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 43, 3–18 (1998).
• 15) Leone, G. et al. PVA/STMP based hydrogels as potential substitutes of human vitreous. J Mater Sci Mater Med. 21, 2491–2500 (2010).
• 16) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
• 17) Wang, P. et al. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Experiment Ophthalmol. 40, e67–75 (2012).
• 18) Chen, J. et al. Clinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye. J Biomed Mater Res B Appl Biomater. 97, 396–404 (2011).
• 19) Maruoka, S. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res. 31, 599–606 (2006).
• 20) Hara, Y. et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Nihon Ganka Gakkai Zasshi. 102, 247–255 (1998).
• 21) Jiang, Z. et al. Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body. Int J Nanomedicine.7, 1–10 (2012).
• 22) Jiang, Z. et al. Evaluation of levofloxacin release characteristics from a human foldable capsular vitreous body in vitro. J Ocul Pharmacol Ther. 28, 33–40 (2012).
• 23) Liu, Y. et al. Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body. Invest Ophthalmol Vis Sci. 51, 1636–1642 (2010).
• 24) Zheng, H. et al. Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo. Graefes Arch Clin Exp Ophthalmol. 250, 751-759 (2012).
• 25) Chen, X. et al. Protein kinase Calpha downregulation via siRNA-PKCalpha released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells. Int J Nanomedicine. 6, 1303–1311 (2011).